Rajan Verma

About Rajan Verma

As the Director of Product Development at Abbott’s R&D center, I lead a dynamic team focused on innovation-driven projects across diverse dosage forms. In my expanded role, I oversee both regional and global product development initiatives, guiding programs from ideation through to commercial launch with a strong emphasis on improving patient outcomes. Additionally, as the administrative Site Director, I am responsible for site operations and compliance of R&D center in Mumbai. As an Associate Research Fellow within Abbott’s distinguished Volwiler Society, I am driven by a deep commitment to scientific excellence and transformative innovation that make a meaningful impact. With over two decades of experience in pharmaceutical development, I am passionate about driving patient-centric innovations. I have honed my expertise in developing NDAs, 505(b)(2) branded generics, and ANDAs for both prescription (Rx) and consumer healthcare (OTC) products. My journey has taken me through leading companies such as Perrigo Labs, Ferring Pharmaceuticals, Dr. Reddy’s Labs, and Sun Pharmaceuticals (formerly Ranbaxy Labs), where I led product development teams through early and late-stage development, scale-up activities, clinical trial manufacturing, and technology transfer.My academic credentials include a Ph.D. in Pharmaceutical Sciences from NIPER, Mohali, and an Executive Program in Business Management from IIM, Calcutta. I am committed to continuous learning, regularly upgrading my knowledge through courses in Generative Artificial Intelligence, Design Thinking, Lean Six Sigma, and more.Key skills and accomplishments:• Product Development: Spearheaded the development and launch of differentiated dosage forms based on patient insights, including Modified release, Compact and EazyGlide® tablets, Multi-matrix technology, Gummies, Orally disintegrating strips, Nasal delivery systems, and Pre-filled syringes.• Navigating complex IP landscape: Proven track record of successfully circumventing patents to develop non-infringing formulations and built strong IP around products, with over 30 patent applications filed and 6 granted patents.• Scholarly Contributions: Authored over 15+ publications (including a book chapter) in peer-reviewed journals, covering drug delivery and product development. • Thought Leadership: Invited speaker on topics such as product development, Insight Driven Innovations for Better Patient Compliance, 505(b)(2) Approval Pathway, QbD in Pharmaceutical Development, and IVIVC in Product Development.

Experience

1. Volwiler Associate Research Fellow

   Abbott

   Nov 2025 — Present · Mumbai, IN

Education

• Indian Institute of Technology (Banaras Hindu University), Varanasi

  M. Pharm., Pharmaceutics

  1996 — 1998

• Delhi University

  D. Pharm., Pharmacy

  1990 — 1992

• College of Pharmacy (DIPSAR)

  B. Pharm., Pharmaceutical Sciences

  1993 — 1996

• National Institute of Pharmaceutical Education and Research

  Ph.D., Osmotic drug delivery

  1998 — 2002

• Indian Institute of Management, Calcutta

  Executive Program in Business Management, General Management

  2010 — 2011

Skills

• Formulation Development
• Generics
• Drug Delivery
• Pharmaceutical Development
• Ndds
• Ivivc
• Nda and 505b2
• Product Development
• Nda
• Formulation
• Generic Programming
• Pharmaceutics
• Pharmaceutical Research
• Gmp
• Analytical Chemistry
• Anda
• Dissolution
• Pharmaceutical Industry
• Validation
• Glp
• Hplc
• Regulatory Affairs
• Sop
• Clinical Trials
• Cmc
• Regulatory Submissions
• Abbreviated New Drug Application (Anda)
• Quality by Design
• Lean Six Sigma